Long-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: Results from the prospective vitamins and lifestyle (VITAL) study

Journal of Clinical Oncology

Volumn 29, Issue 17, 2011, Pages 2424-2431

  Walter, Roland B ^a,b   Milano, Filippo ^a   Brasky, Theodore M ^a,b   White, Emily ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTHRITIS; ARTICLE; B CELL LEUKEMIA; CANCER FATIGUE; CANCER REGISTRY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; COHORT ANALYSIS; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; EDUCATIONAL STATUS; ETHNICITY; FAMILY HISTORY; FEMALE; HEADACHE; HEALTH STATUS; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; LONG TERM CARE; LOW DRUG DOSE; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MUSCULOSKELETAL PAIN; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; SMOKING; T CELL LEUKEMIA; TREATMENT DURATION;

ACETAMINOPHEN; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COHORT STUDIES; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; SEX CHARACTERISTICS;

EID: 79959280767     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.34.6346     Document Type: Article

References (27)

1. Mantovani A, Allavena P, Sica A, et al: Cancer-related inflammation. Nature 454:436-444, 2008
2. Robak P, Smolewski P, Robak T: The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies. Leuk Lymphoma 49:1452-1462, 2008
3. Bernatsky S, Lee JL, Rahme E: Non-Hodgkin's lymphoma-meta-analyses of the effects of corticosteroids and non-steroidal anti-inflammatories. Rheumatology (Oxford) 46:690-694, 2007 (Pubitemid 46523318)
4. Chang ET, Cronin-Fenton DP, Friis S, et al: Aspirin and other nonsteroidal anti-inflammatory drugs in relation to Hodgkin lymphoma risk in northern Denmark. Cancer Epidemiol Biomarkers Prev 19:59-64, 2010
5. Becker N, Fortuny J, Alvaro T, et al: Medical history and risk of lymphoma: Results of a European case-control study (EPILYMPH). J Cancer Res Clin Oncol 135:1099-1107, 2009
6. White E, Patterson RE, Kristal AR, et al: VITamins And Lifestyle cohort study: Study design and characteristics of supplement users. Am J Epidemiol 159:83-93, 2004 (Pubitemid 38049425)
7. Swerdlow SH, Campo E, Harris NL, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed 4). Geneva, Switzerland, WHO Press, 2008
8. Lin DY, Wei LJ: The robust interference for the Cox proportional hazards model. J Am Stat Assoc 84:1074-1078, 1989
9. Cerhan JR, Anderson KE, Janney CA, et al: Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma. Int J Cancer 106:784-788, 2003 (Pubitemid 36993403)
10. Weiss JR, Baker JA, Baer MR, et al: Opposing effects of aspirin and acetaminophen use on risk of adult acute leukemia. Leuk Res 30:164-169, 2006 (Pubitemid 41773336)
11. Chang ET, Zheng T, Weir EG, et al: Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study. J Natl Cancer Inst 96:305-315, 2004 (Pubitemid 38256275)
12. Baker JA, Weiss JR, Czuczman MS, et al: Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma. Cancer Causes Control 16:301-308, 2005
13. Holly EA, Lele C, Bracci PM, et al: Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol 150:375-389, 1999 (Pubitemid 29383486)
14. Kato I, Koenig KL, Shore RE, et al: Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States). Cancer Causes Control 13:965-974, 2002 (Pubitemid 36169480)
15. Moysich KB, Bonner MR, Beehler GP, et al: Regular analgesic use and risk of multiple myeloma. Leuk Res 31:547-551, 2007 (Pubitemid 46198940)
16. McCredie M, Stewart JH, Ford JM, et al: Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women. Br J Urol 55:220-224, 1983 (Pubitemid 13118891)
17. Piper JM, Tonascia J, Matanoski GM: Heavy phenacetin use and bladder cancer in women aged 20 to 49 years. N Engl J Med 313:292-295, 1985 (Pubitemid 15044231)
18. Bergman K, Müller L, Teigen SW: Series: Current issues in mutagenesis and carcinogenesis, No. 65. The genotoxicity and carcinogenicity of paracetamol: A regulatory (re)view. Mutat Res 349:263-288, 1996
19. Bender RP, Lindsey RH Jr, Burden DA, et al: N-acetyl-p-benzoquinone imine, the toxic metabolite of acetaminophen, is a topoisomerase II poison. Biochemistry 43:3731-3739, 2004 (Pubitemid 38391728)
20. Oberly TJ, Bewsey BJ, Probst GS: An evaluation of the L5178Y TK+/- mouse lymphoma forward mutation assay using 42 chemicals. Mutat Res 125:291-306, 1984 (Pubitemid 14184386)
21. Majeska JB, Holden HE: Genotoxic effects of p-aminophenol in Chinese hamster ovary and mouse lymphoma cells: Results of a multiple endpoint test. Environ Mol Mutagen 26:163-170, 1995
22. Pommer W, Bronder E, Klimpel A, et al: Urothelial cancer at different tumour sites: Role of smoking and habitual intake of analgesics and laxatives - Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant 14:2892-2897, 1999
23. Armitage JO, Weisenburger DD: New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes - Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 16:2780-2795, 1998 (Pubitemid 28363044)
24. Ng AK, Bernardo MP, Weller E, et al: Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 20:2101-2108, 2002 (Pubitemid 34408801)
25. Allgar VL, Neal RD: Delays in the diagnosis of six cancers: Analysis of data from the National Survey of NHS Patients - Cancer. Br J Cancer 92:1959-1970, 2005
26. Molassiotis A, Wilson B, Brunton L, et al: Mapping patients' experiences from initial change in health to cancer diagnosis: A qualitative exploration of patient and system factors mediating this process. Eur J Cancer Care (Engl) 19:98-109, 2010
27. Kyle RA, Gertz MA, Witzig TE, et al: Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78:21-33, 2003 (Pubitemid 36033957)